אופטלגין זריקות

Country: Israel

Language: Hebrew

Source: Ministry of Health

Active ingredient:

DIPYRONE 1 G / 2 ML

Available from:

TEVA PHARMACEUTICAL INDUST.LTD

ATC code:

N02BB02

Pharmaceutical form:

SOLUTION FOR INJECTION

Administration route:

I.M, I.V

Manufactured by:

TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY

Therapeutic group:

METAMIZOLE SODIUM

Therapeutic indications:

As an analgesic: Optalgin injection, by intravenous administration, is indicated for the relief of severe and acute pain when oral treatment is not feasible or suitable, as in post-traumatic or post-surgical pain, biliary or renal colic, and pain associated with malignant diseases. Intravenous administration of dipyrone should be carried out slowly over a period of at least 5 minutes, followed by reasonable clinical observation. Intramuscular administration of dipyrone for relief of pain is not recommended.However, if medical circumstances require such administration, all due precautions should be exercised to permit reasonable clinical observation. As an antipyretic: Optalgin injection by intramuscular administration is indicated to lower temperature in life-threatening situations, when this cannot be achieved by other means. Hyperthermic patients in critical condition may also be treated in non-hospital environment, under close medical supervision.

Authorization date:

2011-08-01